Bionomics | Investor Presentation Deck

Slide schematic 3/3

image 1/1 table 1/1 title 1/1

Components 3

illustration data headline

Tools 1

table/data: Study Design: Multi-center, randomized, double-blind, placebo-controlled; BNC210 150 mg, 300 mg, 600 mg and placebo (1:1:1:1); 12-week treatment period; 193 participants; 20 US sites / 6 Australian sites. Key

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

clinical-trial-design 80%

Structured presentation of study design, criteria, and objectives.

Find anything

The slide uses a structured table layout to define the clinical trial parameters.